These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31247891)

  • 21. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica.
    Edwards J; Brown M; Peak E; Bartholomew B; Nash RJ; Hoffmann KF
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003604. PubMed ID: 25768432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia.
    Elliott TP; Kelley JM; Rawlin G; Spithill TW
    Vet Parasitol; 2015 Apr; 209(1-2):117-24. PubMed ID: 25771931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of a novel panel of polymorphic microsatellite loci for the liver fluke, Fasciola hepatica, using a next generation sequencing approach.
    Cwiklinski K; Allen K; LaCourse J; Williams DJ; Paterson S; Hodgkinson JE
    Infect Genet Evol; 2015 Jun; 32():298-304. PubMed ID: 25796359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex and vaccination: Insights from female rats vaccinated with juvenile-specific proteases from Fasciola hepatica.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 May; 255():91-96. PubMed ID: 29773143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of a new peptide derived from Fasciola gigantica cathepsin L1 with potential application in serodiagnosis of fascioliasis.
    Meshgi B; Jalousian F; Fathi S; Jahani Z
    Exp Parasitol; 2018 Jun; 189():76-86. PubMed ID: 29679594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen and fibrin are novel substrates for Fasciola hepatica cathepsin L peptidases.
    Mebius MM; Op Heij JMJ; Tielens AGM; de Groot PG; Urbanus RT; van Hellemond JJ
    Mol Biochem Parasitol; 2018 Apr; 221():10-13. PubMed ID: 29414671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorobenzoyl dipeptidyl derivatives as inhibitors of the Fasciola hepatica cysteine protease cathepsin L1.
    Moran BW; Anderson FP; Ruth DM; Fágáin CO; Dalton JP; Kenny PT
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):1-12. PubMed ID: 20030504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular docking and dynamic simulations of quinoxaline 1,4-di-N-oxide as inhibitors for targets from Trypanosoma cruzi, Trichomonas vaginalis, and Fasciola hepatica.
    González-González A; Méndez-Álvarez D; Vázquez-Jiménez LK; Delgado-Maldonado T; Ortiz-Pérez E; Paz-González AD; Bandyopadhyay D; Rivera G
    J Mol Model; 2023 May; 29(6):180. PubMed ID: 37195391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
    Mulcahy G; Dalton JP
    Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica.
    Cancela M; Acosta D; Rinaldi G; Silva E; Durán R; Roche L; Zaha A; Carmona C; Tort JF
    Biochimie; 2008 Oct; 90(10):1461-75. PubMed ID: 18573308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult and juvenile Fasciola cathepsin L proteases: different enzymes for different roles.
    Norbury LJ; Beckham S; Pike RN; Grams R; Spithill TW; Fecondo JV; Smooker PM
    Biochimie; 2011 Mar; 93(3):604-11. PubMed ID: 21167899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens.
    Jayaraj R; Piedrafita D; Dynon K; Grams R; Spithill TW; Smooker PM
    Vet Parasitol; 2009 Mar; 160(3-4):230-6. PubMed ID: 19081192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
    Quiliano M; Pabón A; Ramirez-Calderon G; Barea C; Deharo E; Galiano S; Aldana I
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1820-1825. PubMed ID: 28291694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.
    Dalton JP; Robinson MW; Mulcahy G; O'Neill SM; Donnelly S
    Vet Parasitol; 2013 Aug; 195(3-4):272-85. PubMed ID: 23623183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica.
    Hawthorne SJ; Pagano M; Halton DW; Walker B
    Biochem Biophys Res Commun; 2000 Oct; 277(1):79-82. PubMed ID: 11027643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralization of the activity of a Fasciola hepatica cathepsin L proteinase by anti-cathepsin L antibodies.
    Smith AM; Carmona C; Dowd AJ; McGonigle S; Acosta D; Dalton JP
    Parasite Immunol; 1994 Jun; 16(6):325-8. PubMed ID: 7970870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles.
    Carmona C; Dowd AJ; Smith AM; Dalton JP
    Mol Biochem Parasitol; 1993 Nov; 62(1):9-17. PubMed ID: 8114830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference reduces gut penetration.
    McGonigle L; Mousley A; Marks NJ; Brennan GP; Dalton JP; Spithill TW; Day TA; Maule AG
    Int J Parasitol; 2008 Feb; 38(2):149-55. PubMed ID: 18048044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.